Nationwide recall on certain Ibuprofen and Oxcarbazepine tablets.

By KBJR News 1

Credit: MGN Online

Nationwide recall on certain Ibuprofen and Oxcarbazepine tablets.

July 21, 2014 Updated Jul 21, 2014 at 2:30 PM CST

Columbus, OH (NNWNOW.con) - American Health Packaging has announced the voluntary nationwide recall of Ibuprofen tablets and Oxcarbazepine Tablets.

The recall includes Lot #142588, Expiration Date 01/2016 of Ibuprofen Tablets, USP, 600 mg, in a hospital unit dose presentation that may contain individual blistered doses labeled as Oxcarbazepine Tablets, 300 mg, lot #142544.

The recall is the result of mislabeled inner unit dose blister packaging which could result in patients receiving ibuprofen and missing their scheduled dose of oxcarbazepine.

Ibuprofen 600 mg tablets are indicated for the relief of mild to moderate pain; for relief of the signs and symptoms of rheumatoid arthritis and osteoarthritis; and treatment of primary dysmenorrhea.

Inadvertent consumption of ibuprofen may cause adverse reactions in a number of patients in which use of ibuprofen is contraindicated.

Oxcarbazepine is used for treating certain types of seizures in patients with epilepsy. Failure to receive the proper dose of oxcarbazepine could increase the chances of having a seizure
This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

For more information on this recall, visit: http://www.fda.gov/Safety/Recalls/ucm405989.htm?

To submit a comment on this article, your email address is required. We respect your privacy and your email will not be visible to others nor will it be added to any email lists.